These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10353481)

  • 1. Supplemental immune globulins in sepsis.
    Werdan K
    Clin Chem Lab Med; 1999 Mar; 37(3):341-9. PubMed ID: 10353481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of septic shock and multiple organ dysfunction syndrome and various therapeutic approaches with special emphasis on immunoglobulins.
    Werdan K
    Ther Apher; 2001 Apr; 5(2):115-22. PubMed ID: 11354295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplemental immune globulins in sepsis: a critical appraisal.
    Werdan K; Pilz G
    Clin Exp Immunol; 1996 May; 104 Suppl 1():83-90. PubMed ID: 8625550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis?
    Di Rosa R; Pietrosanti M; Luzi G; Salemi S; D'Amelio R
    Eur J Intern Med; 2014 Jul; 25(6):511-6. PubMed ID: 24877856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study.
    Werdan K; Pilz G; Bujdoso O; Fraunberger P; Neeser G; Schmieder RE; Viell B; Marget W; Seewald M; Walger P; Stuttmann R; Speichermann N; Peckelsen C; Kurowski V; Osterhues HH; Verner L; Neumann R; Müller-Werdan U;
    Crit Care Med; 2007 Dec; 35(12):2693-2701. PubMed ID: 18074471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients.
    Cometta A; Baumgartner JD; Glauser MP
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):69-72. PubMed ID: 8033438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin for prophylaxis and therapy of sepsis.
    Werdan K
    Curr Opin Crit Care; 2001 Oct; 7(5):354-61. PubMed ID: 11805533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.
    Jarczak D; Kluge S; Nierhaus A
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32756325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness.
    Busani S; Damiani E; Cavazzuti I; Donati A; Girardis M
    Minerva Anestesiol; 2016 May; 82(5):559-72. PubMed ID: 26474267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of IgM-enriched immunoglobulin in adult patients with sepsis.
    Kakoullis L; Pantzaris ND; Platanaki C; Lagadinou M; Papachristodoulou E; Velissaris D
    J Crit Care; 2018 Oct; 47():30-35. PubMed ID: 29886064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulins in sepsis and septic shock].
    Salinas J; Fica A
    Rev Chilena Infectol; 2005 Mar; 22(1):21-31. PubMed ID: 15798866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
    Norrby-Teglund A; Haque KN; Hammarström L
    J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
    Neugebauer EA
    Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
    [No Abstract]   [Full Text] [Related]  

  • 17. The significance of immunoglobulins in the treatment of patients with sepsis and septic shock.
    Bojić I; Begović V; Trnjak Z; Dokić M
    Vojnosanit Pregl; 1998; 55(2 Suppl):75-8. PubMed ID: 9623363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin for adjunctive treatment of severe infections in ICUs.
    Aubron C; Berteau F; Sparrow RL
    Curr Opin Crit Care; 2019 Oct; 25(5):417-422. PubMed ID: 31335381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High doses of immunoglobulins decrease mortality rate of surgical patients with severe intraabdominal infections and sepsis.
    Marenović T; Filipović D; Lukić Z; Dokić G
    Vojnosanit Pregl; 1998; 55(2 Suppl):71-4. PubMed ID: 9623362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.